World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
46
Citations
8293
World Ranking
4617
National Ranking
2080

Overview

Mieko Toyoda is affiliated with Cedars-Sinai Medical Center in the United States. The main field of study for this researcher is Medicine, with a focused emphasis on several subfields, including Transplantation, Epidemiology, Infectious Diseases, Immunology, and Oncology.

Their research covers a range of topics largely related to transplantation and infectious disease processes. Key topics of study include:

  • Renal Transplantation Outcomes and Treatments
  • Cytomegalovirus and herpesvirus research
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • Drug-Induced Adverse Reactions
  • Immunodeficiency and Autoimmune Disorders

Recent publications by Mieko Toyoda include:

  • "T cell immune responses to SARS-CoV-2 and variants of concern (Alpha and Delta) in infected and vaccinated individuals," 2021, Cellular and Molecular Immunology
  • "Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia," 2020, Clinical Infectious Diseases
  • "Interleukin-6: An Important Mediator of Allograft Injury," 2020, Transplantation
  • "Evaluation of Clazakizumab (Anti-Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney Allografts," 2022, Kidney International Reports
  • "The role of novel therapeutic approaches for prevention of allosensitization and antibody-mediated rejection," 2020, American Journal of Transplantation

Frequent coauthors in their work include:

  • Stanley C. Jordan
  • Ashley Vo
  • Edmund Huang
  • Noriko Ammerman
  • Shili Ge

Mieko Toyoda's publications are often featured in the following venues:

  • Transplantation
  • American Journal of Transplantation
  • Pediatric Transplantation
  • Cellular and Molecular Immunology
  • Clinical Infectious Diseases

Best Publications

  • Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation

    Ashley A Vo;Marina Lukovsky;Mieko Toyoda;Jennifer Wang

  • Evaluation of Intravenous Immunoglobulin as an Agent to Lower Allosensitization and Improve Transplantation in Highly Sensitized Adult Patients with End-Stage Renal Disease: Report of the NIH IG02 Trial

    Stanley C. Jordan;Stanley C. Jordan;Dolly Tyan;Don Stablein;Matthew McIntosh

  • Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients.

    McDiarmid Sv;Jordan S;Kim Gs;Toyoda M

  • IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation.

    Stanley C. Jordan;Tomas Lorant;Jua Choi;Christian Kjellman

  • Assessment of Tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients.

    Jua Choi;Olivier Aubert;Ashley Vo;Alexandre Loupy

  • Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.

    Ashley A. Vo;Alice Peng;Mieko Toyoda;Joseph Kahwaji

  • Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients.

    S. C. Jordan;A. Vo;S. Bunnapradist;M. Toyoda

  • Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection: Therapeutic Implications of IL-6 Receptor Blockade.

    Stanley C. Jordan;Jua Choi;Irene Kim;Gordon Wu

  • Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy

    Asha Moudgil;Cynthia C. Nast;Arvind Bagga;Lin Wei

  • A Phase I/II Trial of the Interleukin-6 Receptor–Specific Humanized Monoclonal (Tocilizumab) + Intravenous Immunoglobulin in Difficult to Desensitize Patients

    Ashley A. Vo;Jua Choi;Irene Kim;Sabrina Louie

  • Intravenous gammaglobulin (IVIG): a novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients.

    S. C. Jordan;A. A. Vo;A. Peng;M. Toyoda

  • Clinical Aspects of Intravenous Immunoglobulin Use in Solid Organ Transplant Recipients

    S. C. Jordan;M. Toyoda;J. Kahwaji;A. A. Vo

  • A phase I/II placebo-controlled trial of C1-inhibitor for prevention of antibody-mediated rejection in HLA sensitized patients.

    Ashley A. Vo;Adriana Zeevi;Jua Choi;Kristen Cisneros

  • The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation

    Ragini Fredrich;Mieko Toyoda;Lawrence S.c. Czer;Karine Galfayan

  • Benefits of rituximab combined with intravenous immunoglobulin for desensitization in kidney transplant recipients.

    Ashley A. Vo;Jua Choi;Kristen Cisneros;Nancy Reinsmoen

  • Intravenous immunoglobulin a natural regulator of immunity and inflammation.

    Stanley C. Jordan;Mieko Toyoda;Ashley A. Vo

  • Cellular immune responses to cytomegalovirus in renal transplant recipients.

    Raju Radha;Stanley Jordan;Dechu Puliyanda;Suphamai Bunnapradist

  • Infectious complications in kidney-transplant recipients desensitized with rituximab and intravenous immunoglobulin.

    Joseph Kahwaji;Aditi Sinha;Mieko Toyoda;Shili Ge

  • Current approaches to treatment of antibody-mediated rejection.

    Stanley C. Jordan;Ashley A. Vo;Dolly Tyan;Cynthia C. Nast

  • Pooled human gammaglobulin modulates surface molecule expression and induces apoptosis in human B cells.

    Mieko Toyoda;Andy Pao;Anna Petrosian;Stanley C. Jordan

  • Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient.

    D.P. Puliyanda;N.S. Silverman;D. Lehman;A. Vo

Frequent Co-Authors

Stanley C. Jordan
Stanley C. Jordan Cedars-Sinai Medical Center
Mark Haas
Mark Haas Cedars-Sinai Medical Center
David W. P. Thomas
David W. P. Thomas University of Nottingham
Mikael Knip
Mikael Knip University of Helsinki
David L. Thomas
David L. Thomas Johns Hopkins University
John S. Adams
John S. Adams University of California, Los Angeles
Masato Kasuga
Masato Kasuga National Center For Global Health and Medicine
Lars Bäckman
Lars Bäckman Karolinska Institute
Mats Bengtsson
Mats Bengtsson Royal Institute of Technology
Erik G. Larsson
Erik G. Larsson Linköping University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Nursing pathways, for instance, often intersect with immunological knowledge, especially in areas like infectious diseases and patient care.

Many aspiring nurses benefit from flexible learning options such as the 12-month accelerated nursing programs, which allow quicker entry into the workforce. Similarly, those seeking foundational nursing roles might consider easy admission LPN programs that provide accessible pathways into nursing careers.

For advanced practice roles, pursuing the easiest nurse practitioner program can be a strategic choice for balancing studies with professional demands. This is particularly relevant for those aiming to integrate immunological expertise in clinical settings.

Additionally, specialized fields like mental health nursing benefit from immunological insights. Programs such as the best online psychiatric mental health nurse practitioner programs offer robust clinical placements, preparing graduates for impactful careers at the intersection of immunology and mental health.

Best Scientists Citing Mieko Toyoda

Trending Scientists